An update on the biology of sphingosine 1-phosphate receptors
Open accessThe DOI matches its Crossref record; 180 of the 184 references it cites were found in a registry or an index.
Abstract
Sphingosine 1-phosphate (S1P) is a membrane-derived lysophospholipid that acts primarily as an ex-tracellular signaling molecule. Signals initiated by S1P are transduced by five G protein-coupled receptors, named S1P1-5 Cellular and temporal expression of the S1P receptors (S1PRs) determine their specific roles in various organ systems, but they are particularly critical for regulation of the cardiovascular, immune, and nervous systems, with the most well-known contributions of S1PR signaling being modulation of vascular barrier function, vascular tone, and regulation of lymphocyte trafficking. However, our knowledge of S1PR biology is rapidly increasing as they become attractive therapeutic targets in several diseases, such as chronic inflammatory pathologies, autoimmunity, and cancer. Understanding how the S1PRs regulate interactions between biological systems will allow for greater efficacy in this novel therapeutic strategy as well as characterization of complex physiological networks. Because of the rapidly expanding body of research, this review will focus on the most recent advances in S1PRs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas DCs express S1PR1, S1PR3 and S1PR4, T cells display S1PR1 and S1PR4 (refs164–166)”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [166]
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Cited by
Items 301–400 of 548
Ohno, H., Honda, M., Hamada, N., Miyagaki, J., Iwata, A., Otsuki, K., Maruyama, T., Nakamura, S., Nakanishi, I., Inuki, S., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.03.059 · Cited by 13
Increased plasma apoM levels impair triglyceride turnover in mice
Hajny, S., Borup, A., Elsøe, S., & Christoffersen, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158969 · Cited by 14
Bernacchioni, C., Squecco, R., Gamberi, T., Ghini, V., Schumacher, F., Mannelli, M., Garella, R., Idrizaj, E., Cencetti, F., Puliti, E., et al. (2022) · Cells · doi:10.3390/cells11040713 · Cited by 14
“S1P exerts its functions either as intracellular messenger or as a ligand of five specific G-protein coupled receptors named S1P receptors (S1PR) [18].”
BackgroundInfluentialMartín‐Hernández, D., Muñoz‐López, M., Tendilla‐Beltrán, H., Caso, J. R., García‐Bueno, B., Menchen, L. A., & Leza, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612634 · Cited by 16
Okada, Y. (2024) · The Journal of Physiological Sciences · doi:10.1186/s12576-024-00926-3 · Cited by 12
“A pleiotropic lipid mediator S1P plays a significant role in inflammation [59, 60] and is known to be released from the inflamed cells [61–63].”
BackgroundTian, J., Chen, J., Sun, Q., Huang, T., Xu, H., Wang, J., & Ma, Z. (2024) · Inflammation · doi:10.1007/s10753-024-02118-y · Cited by 12
Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators
Jun, Y. K., & Yoon, H. (2024) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.064 · Cited by 13
Intercellular sphingolipid signaling mediates aversive learning in C. elegans
Wu, Y., Beets, I., Fox, B. W., Palomino, D. F., Chen, L., Liao, C., Vandewyer, E., Lin, L.-Y., He, C.-W., Chen, L., et al. (2025) · Current Biology · doi:10.1016/j.cub.2025.03.082 · Cited by 12
Sphingosine 1-phosphate pathway is dysregulated in adenomyosis
Vannuzzi, V., Bernacchioni, C., Muccilli, A., Castiglione, F., Nozzoli, F., Vannuccini, S., Capezzuoli, T., Ceccaroni, M., Bruni, P., Donati, C., et al. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.03.026 · Cited by 12
Li, X., Pu, X., Wang, X., Wang, J., Liao, X., Huang, Z., & Yin, G. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123306 · Cited by 13
What’s new about oral treatments in Multiple Sclerosis? Immunogenetics still under question
Pistono, C., Osera, C., Boiocchi, C., Mallucci, G., Cuccia, M., Bergamaschi, R., & Pascale, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.025 · Cited by 15
Rational design of SphK inhibitors using crystal structures aided by computer
Ding, T., Zhi, Y., Xie, W., Yao, Q., & Liu, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113164 · Cited by 13
Zhu, N., Zhang, C., Prakash, A. K., Hou, Z., Liu, W., She, W., Morris, A. J., & Kim, K. S. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012651 · Cited by 13
Liu, Z., Yang, H., Zhi, L., Xue, H., Lu, Z., Zhao, Y., Cui, L., Liu, T., Ren, S., He, P. F., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.683674 · Cited by 16
Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities
Blaho, V. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50621-6_6 · Cited by 12
Self-citationDecoding TGR5: A comprehensive review of its impact on cerebral diseases
Zhang, Z., Zhang, Y., Peng, H., Yu, Q., Kang, X., Liu, Y., Zheng, Y., Cheng, F., Wang, X., & Li, F. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107671 · Cited by 12
Arroyo-Urea, E. M., Muñoz-Hernando, M., Leo-Barriga, M., Herranz, F., & González-Paredes, A. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2179128 · Cited by 11
“…et al., 2011) and activation of sphingosine-1-phosphate (S1P) receptors (S1PRs), which are becoming more widely recognized as important regulators of homeostasis and disease for their role in cell survival, activation status and proliferation in all biological systems (Blaho & Hla, 2014).”
BackgroundSanchez, M., Sepahi, A., Casadei, E., & Salinas, I. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.05.051 · Cited by 11
“Uptake mechanisms at other tissue barriers such as the gills or skin have not been investigated, but sphingolipid-derived metabolites such as ceramide and S1P can be taken up by cells by different mechanisms including binding to Gprotein coupled receptors (Blaho and Hla, 2014).”
BackgroundWang, L.-Y., Sun, X., Wang, C., Chen, S., Li, Z., Chen, M., Little, M. A., & Zhao, M. (2020) · Clinical Science · doi:10.1042/cs20200497 · Cited by 12
S1P2-Gα12Signaling Controls Astrocytic Glutamate Uptake and Mitochondrial Oxygen Consumption
Jonnalagadda, D., Kihara, Y., Rivera, R. R., & Chun, J. J. M. (2021) · eNeuro · doi:10.1523/eneuro.0040-21.2021 · Cited by 11
“FTY720 is a prodrug approved as a medicine for MS patients that must be phosphorylated to become an active agent (FTY720-P), where it acts a structural analog of sphingosine 1-phosphate (S1P; Blaho and Hla, 2014) to target S1P1,3,4,5 (Brinkmann et al., 2002; Mandala et al., 2002).”
BackgroundPotential Drug Targets for Ceramide Metabolism in Cardiovascular Disease
Guo, J., Feng, J., Qu, H., Xu, H., & Zhou, H. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120434 · Cited by 12
“As an important intracellular phospholipid mediator, S1P functions intracellularly as a second messenger, and also extracellularly as a G protein-coupled receptor (GPCR) ligand [92,93].”
BackgroundSaurabh, K., Mbadhi, M. N., Prifti, K. K., Mitchum, K. T., & Frolova, A. I. (2023) · Endocrinology · doi:10.1210/endocr/bqad066 · Cited by 11
Cha, E., Kim, J., Gotina, L., Kim, J., Kim, H. J., Seo, S. H., Park, J., Joo, J., Kang, M.-S., Lee, J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00498 · Cited by 10
Perry, T., Masand, N., Vrzalikova, K., Pugh, M., Wei, W., Hollows, R. J., Bouchalová, K., Nohtani, M., Fennell, É., Bouchal, J., et al. (2024) · Cancers · doi:10.3390/cancers16030574 · Cited by 12
Schröder, M., Arlt, O., Schmidt, H., Huwiler, A., Angioni, C., Pfeilschifter, J. M., Schwiebs, A., & Radeke, H. H. (2015) · Biological Chemistry · doi:10.1515/hsz-2014-0287 · Cited by 10
“expression profiles of these five S1PRs – elicits cell-typespecific responses (Blaho and Hla, 2014).”
BackgroundAltered Leukocyte Sphingolipid Pathway in Breast Cancer
Maia, L. P., Santos, P. D. S., Alves, P. T., Rodrigues, C., Araújo, T. G., Maia, Y. C. D. P., Câmara, A., Santos, D. W., & Goulart, L. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122521 · Cited by 11
“The characterization of all five S1PRs in lymphocytes, granulocytes, and monocytes of BC and BCC patients demonstrated that all cell types express the five receptors in both groups, in contrast with a study that has been recently reported elsewhere [19].”
BackgroundResultTargeting Sphingosine Kinase 1 for the Treatment of Pulmonary Arterial Hypertension
Yang, K., Jiang, K., Xu, Z., Song, Y., & Wang, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0130 · Cited by 10
Aktories, K., Gierschik, P., zu Heringdorf, D. M., Schmidt, M., Schultz, G., & Wieland, T. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01650-1 · Cited by 10
Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
Yokoyama, E., Hashimoto, D., Hayase, E., Ara, T., Ogasawara, R., Takahashi, S., Ohigashi, H., Tateno, T., Hasegawa, Y., Chen, X., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0733-8 · Cited by 10
Poormoghadam, D., Almasi, A., Ashrafizadeh, M., Vishkaei, A. S., Rezayat, S. M., & Tavakol, S. (2020) · Nanotechnology · doi:10.1088/1361-6528/ab8d6b · Cited by 11
Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice
Li, F., Xu, R., Lin, C., Low, B. E., Cai, L., Li, S. S. Y., Ji, P., Huang, L., Wiles, M. V., Hannun, Y. A., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001104r · Cited by 10
Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
Schwichtenberg, S., Wisgalla, A., Schroeder-Castagno, M., Álvarez-González, C., Schlickeiser, S., Siebert, N., Bellmann–Strobl, J., Wernecke, K., Paul, F., Dörr, J., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01078-7 · Cited by 11
Nejatian, N., Trautmann, S., Thomas, D., Pfeilschifter, J. M., Badenhoop, K. W. J., Koch, A. H., & Penna-Martinez, M. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.005 · Cited by 10
Santacreu, B. J., Pescio, L. G., Romero, D. J., Corradi, G. R., Sterin-Speziale, N. B., & Favale, N. O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213917 · Cited by 10
Liu, H., Laforest, R. A., Gu, J., Luo, Z., Jones, L. A., Gropler, R. J., Benzinger, T. L. S., & Tu, Z. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01380-z · Cited by 12
Gao, S., Guo, T., Luo, S., Zhang, Y., Ren, Z., Lang, X., Hu, G., Zuo, D., Jia, W., Kong, D., et al. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.023 · Cited by 9
“S1PR1-3 are ubiquitously expressed in most cells, whereas S1PR4 and S1PR5 are less abundant and are restricted to distinct cells (Blaho and Hla, 2014).”
BackgroundHuang, F., Du, Y., Zhang, X., Guan, L., Liu, X., & Zeng, M. (2023) · Journal of Applied Toxicology · doi:10.1002/jat.4467 · Cited by 9
“Owing to the antagonism between S1P receptor subtypes, the role of S1P in different models does not seem to be completely consistent, and the role of S1P remains controversial (Blaho & Hla, 2014; Spiegel & Milstien, 2003; E. Wang et al., 2019).”
BackgroundTalmont, F., Moulédous, L., Baranger, M., Gomez‐Brouchet, A., Zajac, J., Deffaud, C., Cuvillier, O., & Hatzoglou, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213203 · Cited by 9
Habek, M., Crnošija, L., Junaković, A., Adamec, I., Barun, B., Gabelić, T., & Skorić, M. K. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.11.022 · Cited by 9
Riese, J., Gromann, A., Lührs, F., Kleinwort, A., & Schulze, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073465 · Cited by 9
“Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid involved in regulating a plethora of biological processes (reviewed in [16,17]).”
BackgroundRomero, D. J., Pescio, L. G., Santacreu, B. J., Mosca, J. M., Sterin-Speziale, N. B., & Favale, N. O. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121404 · Cited by 9
Imeri, F., Tanturovska, B. S., Manaila, R., Pavenstädt, H., Pfeilschifter, J. M., & Huwiler, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043267 · Cited by 9
Ikeda, K., Koga, T., Sasaki, F., Ueno, A., Saeki, K., Okuno, T., & Yokomizo, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.165 · Cited by 9
Panta, C. R., Ruisanchez, É., Móré, D., Dancs, P. T., Balogh, A., Fülöp, Á., Kerék, M., Proia, R. L., Offermanns, S., Tigyi, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246361 · Cited by 9
“Therefore, the S1P2–G12/13–ROCK pathway appears to be a promising therapeutic target in thromboembolic disorders of the cardiovascular system [42].”
BackgroundMouse Liver Compensates Loss of Sgpl1 by Secretion of Sphingolipids into Blood and Bile
Spohner, A. K., Jakobi, K., Trautmann, S., Thomas, D., Schumacher, F., Kleuser, B., Lütjohann, D., El-Hindi, K., Grösch, S., Pfeilschifter, J. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910617 · Cited by 9
Alipour, H., Alizadeh, A. A., Azarpira, N., Saudi, A., Alavi, O., Tanideh, N., & Dehghani, F. (2022) · Polymers for Advanced Technologies · doi:10.1002/pat.5715 · Cited by 9
Lee, K. P., Baek, S., Jung, S. H., Cui, L., Lee, D., Lee, D.-Y., Choi, W. S., Chung, H. W., Lee, B. H., Kim, B., et al. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2132-1 · Cited by 9
“S1P transmits its signal into intracellular spaces via its G-protein-coupled cell surface receptors, such as S1P receptors (S1PRs) [1, 33].”
Miyagawa, T., Inuki, S., Honda, M., Nakamura, S., Nakanishi, I., Fujii, N., Oishi, S., & Ohno, H. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.02.042 · Cited by 9
Estrada, S. M., Thagard, A. S., Dehart, M. J., Damicis, J. R., Dornisch, E. M., Ippolito, D. L., Burd, I. D., Napolitano, P. G., & Ieronimakis, N. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2682-y · Cited by 9
Sphingolipid signaling in kidney diseases
Li, N., & Li, G. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00193.2024 · Cited by 9
Barrier Abnormalities in Type 1 Diabetes Mellitus: The Roles of Inflammation and Ceramide Metabolism
Shin, K., Kim, B., Choi, Y., Bae, Y., Park, J., Park, S., Hwang, J.-T., Choi, E. H., Uchida, Y., & Park, K. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.10.010 · Cited by 10
Liu, H., Zhang, Z., Li, P., Yuan, X., Zheng, J., Liu, J., Bai, C., & Niu, W. (2016) · PeerJ · doi:10.7717/peerj.2712 · Cited by 8
“Wherein the S1P receptor 1 (S1PR1) has a more important biological role in enhancing endothelial barrier, the S1PR2 suppresses the endothelial barrier function (Blaho & Hla, 2014).”
BackgroundSphingosine‐1‐phosphate‐lyase deficiency affects glucose metabolism in a way that abets oncogenesis
Afsar, S. Y., Alam, S., Gonzalez, C. F., & van Echten‐Deckert, G. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13300 · Cited by 9
Xu, L., Lu, P., & Wang, Y. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-02961-4 · Cited by 8
“In immune system, S1PR1 regulates the transport of lymphocytes from secondary lymphoid organs into blood, inducing peripheral lymphocyte homing [10].”
BackgroundPierucci, F., Chirco, A., & Meacci, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310548 · Cited by 8
Atypical sphingosine-1-phosphate metabolites—biological implications of alkyl chain length
Glueck, M., Lucaciu, A., Subburayalu, J., Kestner, R. I., Pfeilschifter, W., Vutukuri, R., & Pfeilschifter, J. M. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03018-8 · Cited by 8
“…S1P receptors are ubiquitously but differentially expressed depending on the cell type and biological response such as cardiovascular development [3, 16, 72], neural cell proliferation [54, 67, 80], immune cell migration [52], inflammation [82], fibrosis [29, 64] and endothelial function [30,…”
Barbour, M., McNaughton, M., Boomkamp, S. D., MacRitchie, N. A., Jiang, H., Pyne, N. J., & Pyne, S. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13670 · Cited by 8
“Spns2 and certain ABC transporters) and act as a ligand on a family of five S1P-specific GPCRs (S1P1–5) (Blaho and Hla, 2014) or, if retained within the cell, bind to and regulate specific intracellular target proteins.”
BackgroundNakazawa, M., Maeda, S., Yokoyama, N., Nakagawa, T., Yonezawa, T., Koichi, O. H. N. O., & Matsuki, N. (2019) · Journal of Veterinary Medical Science · doi:10.1292/jvms.19-0016 · Cited by 8
“Of the lymphocytes, CD21+ B cells strongly expressed S1P1 and S1P4 relative to the CD3+ T cells (Fig.”
BackgroundInfluentialDifferential gene signature in adipose tissue depots of growth hormone transgenic mice
Duran‐Ortiz, S., Young, J. A., Jara, A., Jensen, E., Basu, R., List, E. O., Qian, Y., Kopchick, J. J., & Berryman, D. E. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12893 · Cited by 8
Asi, T., Aşçı, A., Altan, M., Güdeloğlu, A., & Ergen, A. (2019) · World Journal of Urology · doi:10.1007/s00345-019-03045-6 · Cited by 9
“1 3 Sphingosine-1-phosphate (S1P) is a signaling molecule that has a role in many cellular actions including cell survival, migration and activation [22].”
BackgroundBlankenbach, K. V., Bruno, G., Wondra, E., Spohner, A. K., Aster, N. J., Vienken, H., Trautmann, S., Ferreirós, N., Wieland, T., Bruni, P., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158704 · Cited by 9
Sphingosine 1-Phosphate in Malaria Pathogenesis and Its Implication in Therapeutic Opportunities
Dhangadamajhi, G., & Singh, S. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00353 · Cited by 8
“These S1PRs vary in their distribution and expression in response to various stimuli (Strub et al., 2010; Blaho and Hla, 2014).”
BackgroundSignal Transduction and Gene Regulation in the Endothelium
Levesque, M. V., & Hla, T. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041153 · Cited by 9
Self-citationHashemi, E., Yoseph, E., Tsai, H., Moreno, M. A., Yeh, L.-H., Mehta, S. B., Kono, M., Proia, R. L., & Han, M. H. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01245-0 · Cited by 7
“S1P and its receptors (S1P1-5) are crucial targets for immune regulatory functions such as lymphocyte development, regression, and adaptive immune response (Blaho and Hla 2014; Cyster and Schwab 2012).”
BackgroundMasuda‐Kuroki, K., Alimohammadi, S., Lowry, S., & Nardo, A. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1469829 · Cited by 7
PI3K Signaling at the Crossroads of Lipid Metabolism and Cancer
Yilmaz, S., & Cizmecioglu, O. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_832 · Cited by 7
PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [18F]TZ4877 in Nonhuman Primates
Gu, J., Zheng, M., Holden, D., Fowles, K., Qiu, L., Felchner, Z., Zhang, L., Ropchan, J. R., Gropler, R. J., Carson, R. E., et al. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-024-01979-x · Cited by 8
“Sphingosine-1-phosphate (S1P) is a sphingolipid that potently regulates brain immune responses, classically promoting cellular survival [1].”
P-Rex1 limits the agonist-induced internalization of GPCRs independently of its Rac-GEF activity
Baker, M. J., Hampson, E., Islam, P., Moral, R. P., Maunders, E. A., Hornigold, K., Tsonou, E., Malliri, A., Hornigold, D. C., Hubbard, R. E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116403 · Cited by 7
Basics of Sphingolipid Metabolism and Signalling
Colacios, C., Sabourdy, F., Andrieu‐Abadie, N., Ségui, B., & Levade, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-20750-6_1 · Cited by 8
“Engagement of S1P receptors modulates cell growth, migration, angiogenesis, lymphangiogenesis and the immune response [ 58 ].”
BackgroundAkbari, E., Spychalski, G. B., Menyhert, M. M., Rangharajan, K. K., Tinapple, J. W., Prakash, S., & Song, J. W. (2021) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2021.100020 · Cited by 7
“W146: 5.09×10−4 ± 1.65×10−4 cm·s-1·cmH2O-1, p 0.05 and JTE013: 3.87×10−4 ± 0.96×10−4 cm·s-1·cmH2O-1, p 0.05 (Figure 3Aiii,Biii).”
InfluentialAntagonizing S1P3 Receptor with Cell-Penetrating Pepducins in Skeletal Muscle Fibrosis
Corvino, A., Cerqua, I., Bianco, A. L., Caliendo, G., Fiorino, F., Frecentese, F., Magli, E., Morelli, E., Perissutti, E., Santagada, V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168861 · Cited by 7
“The activation of these receptors can promote opposite cellular responses [2].”
BackgroundSphingosine-1-Phosphate as Lung and Cardiac Vasculature Protecting Agent in SARS-CoV-2 Infection
Karam, M., & Auclair, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713088 · Cited by 7
“S1P is also an agonist of five G-protein-coupled receptors (S1P1-S1P5) [34].”
BackgroundReceptor for Advanced Glycation End Products Regulates Leukotriene B 4 Receptor 1 Signaling
Ichiki, T., Koga, T., & Yokomizo, T. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3552 · Cited by 9
“The vascular S1P gradient is required for lymphocyte trafficking through the chemotactic activity of S1P 1 (Hla et al. , 2008; Blaho and Hla, 2014).”
Wang, J., Kano, K., Saigusa, D., & Aoki, J. (2019) · Mass Spectrometry · doi:10.5702/massspectrometry.a0072 · Cited by 7
FAM19A5/S1PR1 signaling pathway regulates the viability and proliferation of mantle cell lymphoma
Wang, Y., Zhang, Z., Wan, W., Liu, Y., Jing, H., & Dong, F. (2021) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2021.1895220 · Cited by 7
“Five subtypes of S1PR1, S1PR2, S1PR3, S1PR4, and S1PR5 have been found to regulate different physiological functions [42].”
BackgroundInfluentialGiussani, P., Mauri, L., & Sonnino, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211118 · Cited by 7
“In particular, S1P activates complex cascades responsible for the regulation of different cellular processes such as cell migration and angiogenesis [122,128].”
Giussani, P., Brioschi, L., Gjoni, E., Riccitelli, E., & Viani, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158270 · Cited by 6
“In addition, data obtained stimulating cells with S1P in the presence of the pertussis toxin (PTX), a Go/Gi inhibitor (Figure 1B), support that also, in T98G cells, S1P activates the PI3K/Akt pathway through Go/Gi protein-coupled receptors [26,27].”
Backgroundde Assis, J. L., Grelle, G. M. R. S., Fernandes, A. M., Aniceto, B. S., Pompeu, P., Mello, F. V., Garrett, R., Valverde, R. H. F., & Einicker‐Lamas, M. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01038-7 · Cited by 6
“About half of the patients with some kidney damages do not survive, and this picture has not shown significant changes over the last decades [9, 77].”
Safety evaluation of etrasimod for ulcerative colitis based on the FAERS database
Guo, Q., Shan, M., & Gao, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-19679-z · Cited by 6
“S1P1, S1P2 and S1P3 are generally expressed, while the expression of S1P4 is primarily limited to immune cells, and S1P5 is selectively expressed on natural killer cells, T cells, oligodendrocytes and keratinocytes 28–30 .”
Pissarek, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100925 · Cited by 6
Skoug, C., Erdogan, H., Vanherle, L., Vieira, J. P. P., Matthes, F., Eliasson, L., Meißner, A., & Duarte, J. M. N. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04033-4 · Cited by 8
SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment
Zhang, J., Ge, Q., Du, T., Kuang, Y., Fan, Z., Jia, X., Gu, W., Chen, Z., Wei, Z., & Shen, B. (2024) · Life Science Alliance · doi:10.26508/lsa.202402957 · Cited by 6
“S1P activates the S1P receptor 1-5 (S1PR1-5) on cell membranes via autocrine/paracrine action, acting as a fi rst messenger and signi fi cantly in fl uencing lymphatic circulation, cardiovascular development, and intercellular tight junction maintenance (19, 20).”
The role of sphingolipid rheostat in the adult-type diffuse glioma pathogenesis
Karmelić, I., Jurilj, M., Sajko, T., Rotim, K., & Fabris, D. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1466141 · Cited by 6
Immunomodulatory Effects of SPHK1 and Its Interaction with TFAP2A in Yellow Drum (Nibea albiflora)
Han, F., Cui, Y., Luo, S., Wu, B., Li, Q., & Wang, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413641 · Cited by 7
“Extracellularly, S1P functions as a ligand that binds to specific G-protein coupled receptors (GPCRs) such as EDG receptors, triggering downstream signaling pathways that promote cell survival and vascular integrity [15–17].”
Dual action of sphingosine 1-phosphate pathway in in vitro models of global cerebral ischemia
Mazzantini, C., Venturini, M., Lana, D., Mulas, G., Santalmasi, C., Magni, G., Bruni, P., Pugliese, A. M., Cencetti, F., Pellegrini-Giampietro, D. E., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106865 · Cited by 7
Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate.
Wang, X., & Wang, F. (2017) · PubMed Central · doi:10.11909/j.issn.1671-5411.2017.11.010 · Cited by 6
Inuki, S., & Ohno, H. (2021) · Chemistry Letters · doi:10.1246/cl.210133 · Cited by 6
Okada, T., Nishida, S., Zhang, L., Mohamed, N. N. I., Wang, T., Ijuin, T., Kajimoto, T., & Nakamura, S. (2021) · iScience · doi:10.1016/j.isci.2021.103351 · Cited by 7
“Most of these processes are mediated by five S1P-specific G-protein-coupled receptors (GPCRs; S1P1-5Rs) and show distinct expression in tissues and cells, and also unique G-protein-coupling patterns suggesting distinctive cellular functions (Blaho and Hla, 2014; Bryan and Del Poeta, 2018; Rosen et al., 2009).”
BackgroundOlesch, C., Brüne, B., & Weigert, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031289 · Cited by 7
Terlizzi, M., Colarusso, C., Ferraro, G., Falanga, A., Monti, M. C., Somma, P., Rosa, I. D., Panico, L., Pinto, A., & Sorrentino, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310841 · Cited by 6
“We found that lung cancer tissues expressed mainly S1PR1, S1PR2 and S1PR3 (Supplementary Figure S2A), whereas S1PR4 and S1PR5 were undetectable, probably because they are highly restricted to distinct cell types and tissues, such as the lymphoid tissues, brain, and spleen [34].”
BackgroundThe Hunt for the Putative Epoxyeicosatrienoic Acid Receptor
Arnold, W. R., Jain, S. A., Sinha, V., & Das, A. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00047 · Cited by 5
Feng, R., Liu, C., Cui, Z., Liu, Z., & Zhang, Y. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13322 · Cited by 7
Johansen, V. B. I., Hampson, E., Tsonou, E., Pantarelli, C., Chu, J. Y., Crossland, L., Okkenhaug, H., Massey, A. J., Hornigold, D. C., Welch, H. C. E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45148-6 · Cited by 5
Wang, X., Huang, R., Huang, B., & Li, X. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230533 · Cited by 5
“S1PR2 is also expressed in astrocytes [37], which have been identified as key players in neurodegenerative diseases [38].”
Kamyan, D., Hassane, M., Alnaqbi, A., Souid, A., Rasbi, Z. A., Tahrawi, A. A., & Shamsi, M. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1230735 · Cited by 5
“While fi ngolimod (FTY720), the fi rst approved sphingosine-1-phosphate receptor (S1PR) modulator for treatment of MS, targets cells expressing S1P receptors 1, 3, 4 and 5 (12), ozanimod is more selective, only targeting S1PR1 and S1PR5 (16).”
BackgroundLigand-dependent interactions between SR-B1 and S1PR1 in macrophages and atherosclerotic plaques
Bassila, C., Kluck, G. E. G., Thyagarajan, N., Chathely, K. M., González, L., & Trigatti, B. L. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100541 · Cited by 6
“S1PR1, S1PR2, and S1PR3 are ubiquitously expressed, whereas S1PR4 is primarily expressed in lymphoid tissues and S1PR5 is found almost exclusively in the brain and spleen (46, 47).”
Endothelial Cells: A Key Player in Angiogenesis and Lymphangiogenesis
Ren, B. (2014) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2014.01.00015 · Cited by 5
“S1P1 is originally found to be expressed in ECs, but actually it is expressed widely in cultured cells, including both endothelial and mesenchymal cells and other nonvascular cells in adult tissues, and S1P and its receptor are important in EC function, angiogenesis and vascular development [51-55].”
BackgroundPognan, F., Mahl, A., Papoutsi, M., Ledieu, D., Raccuglia, M., Theil, D. J., Voytek, S. B., Devine, P. J., Kubek-Luck, K., Claudio, N., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2189-9 · Cited by 5
“In the case of cancerous tissues formation, tumorinduced angiogenesis is an essential feature of tumor growth (Blaho and Hla 2014; Cuvillier et al. 2013; Kunkel et al. 2013; Pyne and Pyne 2010; Rosen et al. 2013; Takabe and Spiegel 2014; Takuwa et al. 2010).”
BackgroundNishida, S., Matovelo, S. A., Kajimoto, T., Nakamura, S., & Okada, T. (2024) · Communications Biology · doi:10.1038/s42003-024-06828-9 · Cited by 4
Vettorazzi, M., Díaz, I., Angelina, E., Salido, S., Gutiérrez, L. J., Alvarez, S. E., Cobo, J., & Enriz, R. D. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107112 · Cited by 4
Metadata
- Authors
- Blaho, V. A., & Hla, T.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Hla, Timothy
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 55
- Issue
- 8
- Pages
- 1596-1608
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4109755
- OpenAlex
- W2005467120
- Cited by
- 516
- References
- 184
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 35 · 2023: 49 · 2022: 31 · 2021: 59 · 2020: 48 · 2019: 46 · 2018: 52 · 2017: 49 · 2016: 48 · 2015: 29 · 2014: 10
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2239 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (R01HL067330, R37HL067330, R01HL089934, P01HL070694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, lysophospholipids, vascular barrier function, vascular tone, lymphocyte migration, chronic inflammation, autoimmunity, cancer, therapeutic target
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Lysophospholipids, Neoplasm Proteins, Neoplasms, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.